Skip to content
design lab self-driving nissan toyota ford duke stanford e-hmi

Design Lab Collaborates with Amgen to Explore Adoption of Medical Therapies

Design Lab Collaborates with Amgen to Explore Adoption of Medical Therapies

Design Lab Collaborates with Amgen to Explore Adoption of Medical Therapies

The Design Lab has recently embarked on an exciting collaboration with Amgen to explore the mechanisms driving patients to adopt certain medication therapies.  Dr. Eliah Arnoff-Spencer, senior research scientist Colleen Emmenegger, and researcher Lars Mueller of the Design Lab, received a grant to work on a project aimed at understanding the factors that play a role in key medical decisions through applying human-centered design to healthcare.

Through specifically focusing on the elements of automation and trust within different medical capacities, the team seeks to uncover why patients choose to adopt and either continue or subsequently stop certain therapies.   Automated sensors for diabetes and certain medical treatments are among the areas that the team will target within the healthcare space. Emmenegger, the director of the automation program at The Design Lab, noted that trust is a common theme that transcends both the fields of autonomous vehicles and medicine and will serve as a focal point throughout the project.  

The first step in fostering a shared understanding around patient decisions is to delve deeply into the literature surrounding the adoption and continuation of medical therapies.  Following an analysis of the important insights extracted from existing research, the team plans to conduct interviews with a network of stakeholders within the medical space such as physicians, caregivers, supporters and members of product therapy marketing groups.  Developing an understanding of how trust impacts the community and patients will inform the next phases of the project which will consist of observational studies and site visits of patient homes, doctor’s offices and pharmacies. “It’s never just a single person interacting with a single product – multiple people are always involved and there’s a very distributed nature to these interactions,” says Emmenegger. 

The project marks the start of a long-term partnership with Amgen.  Through interacting with individuals who are involved in making key medical decisions and are knowledgeable about the medical therapy adoption life cycle, Emmenegger is looking forward to learning about the impacts of the study within the larger community.  “This project will teach us not only about trust but also about how to humanize healthcare.”

The Design Lab has recently embarked on an exciting collaboration with Amgen to explore the mechanisms driving patients to adopt certain medication therapies.  Dr. Eliah Arnoff-Spencer, senior research scientist Colleen Emmenegger, and researcher Lars Mueller of the Design Lab, received a grant to work on a project aimed at understanding the factors that play a role in key medical decisions through applying human-centered design to healthcare.

Through specifically focusing on the elements of automation and trust within different medical capacities, the team seeks to uncover why patients choose to adopt and either continue or subsequently stop certain therapies.   Automated sensors for diabetes and certain medical treatments are among the areas that the team will target within the healthcare space. Emmenegger, the director of the automation program at The Design Lab, noted that trust is a common theme that transcends both the fields of autonomous vehicles and medicine and will serve as a focal point throughout the project.  

The first step in fostering a shared understanding around patient decisions is to delve deeply into the literature surrounding the adoption and continuation of medical therapies.  Following an analysis of the important insights extracted from existing research, the team plans to conduct interviews with a network of stakeholders within the medical space such as physicians, caregivers, supporters and members of product therapy marketing groups.  Developing an understanding of how trust impacts the community and patients will inform the next phases of the project which will consist of observational studies and site visits of patient homes, doctor’s offices and pharmacies. “It’s never just a single person interacting with a single product – multiple people are always involved and there’s a very distributed nature to these interactions,” says Emmenegger. 

The project marks the start of a long-term partnership with Amgen.  Through interacting with individuals who are involved in making key medical decisions and are knowledgeable about the medical therapy adoption life cycle, Emmenegger is looking forward to learning about the impacts of the study within the larger community.  “This project will teach us not only about trust but also about how to humanize healthcare.”

The Design Lab has recently embarked on an exciting collaboration with Amgen to explore the mechanisms driving patients to adopt certain medication therapies.  Dr. Eliah Arnoff-Spencer, senior research scientist Colleen Emmenegger, and researcher Lars Mueller of the Design Lab, received a grant to work on a project aimed at understanding the factors that play a role in key medical decisions through applying human-centered design to healthcare.

Through specifically focusing on the elements of automation and trust within different medical capacities, the team seeks to uncover why patients choose to adopt and either continue or subsequently stop certain therapies.   Automated sensors for diabetes and certain medical treatments are among the areas that the team will target within the healthcare space. Emmenegger, the director of the automation program at The Design Lab, noted that trust is a common theme that transcends both the fields of autonomous vehicles and medicine and will serve as a focal point throughout the project.  

The first step in fostering a shared understanding around patient decisions is to delve deeply into the literature surrounding the adoption and continuation of medical therapies.  Following an analysis of the important insights extracted from existing research, the team plans to conduct interviews with a network of stakeholders within the medical space such as physicians, caregivers, supporters and members of product therapy marketing groups.  Developing an understanding of how trust impacts the community and patients will inform the next phases of the project which will consist of observational studies and site visits of patient homes, doctor’s offices and pharmacies. “It’s never just a single person interacting with a single product – multiple people are always involved and there’s a very distributed nature to these interactions,” says Emmenegger. 

The project marks the start of a long-term partnership with Amgen.  Through interacting with individuals who are involved in making key medical decisions and are knowledgeable about the medical therapy adoption life cycle, Emmenegger is looking forward to learning about the impacts of the study within the larger community.  “This project will teach us not only about trust but also about how to humanize healthcare.”

Read Next

Seda Evis

Designer in Residence: Seda Evis

While Seda Evis participates as a Designer-in-Residence at UC San Diego with The Design Lab, and is VP of Strategy & Growth at FreshForm Interactive—an experience design and innovation consultancy—she also claims to have what she refers to as a superpower: her hybrid mind, which she describes as the combination of two worlds: the business side and the design side.

As a Designer-in-Residence at The Design Lab,  Evis enjoys working in an interdisciplinary setting, which she says enhances her existing skillset. “Academia tends to be quite separate from how the practice is done,” she explains. “I find ways of doing interdisciplinary work, as well as cross industry work, very important for innovation because that’s how you actually get seeds from different places.” As of now, most of Evis’s work at The Design Lab has been working with the Community Team on the now winning bid for the World Design Capital 2024 (WDC) designation. Her work dovetails with her role on the Board of  Directors for the Design Forward Alliance–a non-profit organization started by the Lab in partnership with the regional design community and one of the partners co-leading the HOME 2024 WDC efforts alongside the Design Lab, Burnham Center for Community Advancement, the City of San Diego and the City of Tijuana.   The designation puts the San Diego-Tijuana region in a prestigious international cohort recognized for the “effective use of design to drive economic, social, cultural and environmental development.”  Even the proposal theme is significant, Evis says. “Home” not only refers to the immense and diverse communities of San Diego and Tijuana that form one, but also serves as an acronym for Human-centered, Open, Multi-disciplinary/Multi-cultural, and Experimental. For Evis, participating in HOME2024 signifies her career “coming full circle.” 
Design Lab Uc San Diego Ailie Fraser Tricia Ngoon

CHI 2018 Conference Spotlights Design Lab Work

This year’s ACM CHI Conference on Human Factors in Computing Systems — more commonly known…

Ucsd Designers In Residence Community Driven

Designers in Residence Support Community-Driven Design Initiatives

In 2019, Grace Reiger and Brian LeDuc uprooted from Washington, DC and set out across the country together for San Diego. They brought them with a wealth of knowledge in community building around design, education and career development. Driven with a mission to spearhead community design initiatives and active communities across San Diego they saw a huge opportunity in bridging their work in Washington, DC with the needs of the San Diego community around service and career design.

"Grace and Brian really exemplify what we strive for in the Design Lab. A community first approach to design - one built on identifying challenges and jointly coming up with tangible solutions with and for those in need of them. We are extremely lucky to have two Designers in Residence on board who embody those principles."

- Michele Morris, Associate Director, Design Lab
Design Lab Ibm

IBM Design Thinking Workshop at The Design Lab

IBM believes in design thinking. And design doing. So much so that throughout the company,…

Design Lab Michele Morris Design Forward Summit Xconomy Uc San Diego

Lab Focused on Human-Centered Design Moves to Put San Diego on Map

Xconomy Article
For Michèle Morris, the big question hanging over organizers as they laid the groundwork last year for the first Design Forward Summit was whether the innovation community in San Diego understood the value of design.

“We didn’t know who was going to show up—and 600 people showed up,” said Morris, who is associate director of the Design Lab at UC San Diego and a founder of the Design Forward Summit.

Now, with the second Design Forward Summit set to begin Wednesday on San Diego’s downtown waterfront (and Thursday in Liberty Station), Morris said the question to be answered this year is “What’s next?”
Design & Innovation Building (DIB) Grand Opening

Design & Innovation Building (DIB) Grand Opening

In commemoration of the Grand Opening of the new Design & Innovation Building, The Design Lab hosted a showcase of projects and activities on Thursday, November 18. UC San Diego faculty, staff, and students were invited to attend, along with special invitees from the San Diego community such as design practitioners, as well as industry and government partners. The Design & Innovation Building will allow The Design Lab to serve an interdisciplinary group of faculty, students, staff, and community partners that are working to solve the most complex societal problems with design.
Back To Top